The single thing that separates a good GLP-1 telehealth provider from a forgettable one is pharmacy accountability. Anyone can spin up a website and write prescriptions. Fewer can tell you exactly which compounding lab filled your vial, what testing that lab ran, and how the medication gets to your door. Start there, and the field thins quickly.
1. HealthRX
Best for: cash-pay patients who want low monthly pricing, named pharmacy sourcing, and overnight shipping to any state.
Compounded semaglutide starts at $99 per month. Compounded tirzepatide starts at $149. Those numbers are among the lowest in the category, and they come with free overnight shipping to all 50 states, which no small number of competitors still cannot match.
The pharmacy is Manifest Pharmacy in Greer, South Carolina, a 503A facility operating under USP-797 standards with lot-level tracking on every shipment. That is specific. Many telehealth brands describe their compounding source in vague terms like “an accredited facility.” HealthRX names the building. LegitScript has certified HealthRX (certification 50087439), which adds an independent verification layer most smaller platforms skip.
The clinical side works like this: complete an online health assessment, and a board-certified U.S. physician reviews it within roughly 24 hours. If approved, medication ships overnight. No long intake calls, no waiting weeks for a slot. The platform is HIPAA-compliant and pricing is published upfront with no surprise fees at checkout.
For context on what the medications can do: the SURMOUNT-1 trial found tirzepatide produced approximately 21% body weight reduction at 72 weeks. The STEP 1 trial found semaglutide produced roughly 15% at 68 weeks. HealthRX cites that trial data honestly rather than making independent efficacy claims, which is the right call. These are compounded medications, not FDA-approved drugs.
Best fit: someone paying out of pocket who wants to know exactly where their medication comes from, get it fast, and not overpay.
2. FormBlends
Best for: patients who want published third-party purity data, or who want GLP-1 medications alongside a broader peptide catalog from one provider.
FormBlends runs a compounded GLP-1 program with physician oversight and dispenses through an FDA-registered 503A compounding pharmacy. What sets it apart is transparency on the testing side. Per-product documentation includes HPLC purity numbers, mass spectrometry identity confirmation, and endotoxin sterility results, with named figures rather than general assurances. That level of public disclosure is rare among GLP-1 telehealth providers.
Pricing is higher than HealthRX. Semaglutide vials are priced at roughly $299 each, with tirzepatide coming in near $349 per vial. If cost is the primary filter, FormBlends loses that comparison. If published purity testing matters to you, or if you want recovery, longevity, or cognitive peptides through the same clinician-supervised model, it earns a serious look. Most GLP-1-only telehealth brands do not carry that broader catalog at all.
Shipping reaches 47 states, not all 50. Worth confirming your state before signing up.
3. Mochi Health
Compounded semaglutide at approximately $99 per month, tirzepatide around $199. The draw here is the clinical model. Mochi staffs board-certified obesity-medicine physicians, which is a meaningful distinction. Obesity medicine is a recognized specialty with specific training around long-term weight management, metabolic health, and medication protocols.
Monitoring is more hands-on than most cash-pay platforms. That suits patients who want ongoing clinical contact rather than a prescription and a goodbye.
4. Ro Body
Ro charges around $39 for the first month of membership, then roughly $74 to $149 per month after that. Medications are billed separately. For patients with insurance, Ro has a prior-authorization team that works to get branded GLP-1s covered. That process takes time, but for someone with decent insurance, the eventual cost can drop substantially.
The platform is well-established. The separation between program fees and medication costs means the sticker price is not the all-in price. Factor both.
5. Hims & Hers
After the March 2026 settlement between Novo Nordisk and the compounding industry, Hims & Hers exited compounded GLP-1 medications and shifted to branded products. Injectable Wegovy runs approximately $299 per month through their platform. Oral semaglutide is around $249. Zepbound is listed near $399. With insurance and a manufacturer savings card, costs can fall to $0 to $25 for eligible patients.
This is the option for someone who specifically wants branded, FDA-approved semaglutide and has insurance or savings card eligibility to offset the price.
6. PlushCare
Membership is about $19.99 per month. PlushCare books same-day telehealth visits and works with insurance for branded medications. The model feels closer to a traditional doctor’s office than a weight-loss-specific platform. If you want your GLP-1 prescription handled alongside other primary care needs, that integration makes sense.
7. Found
Found charges roughly $99 per month for its platform, with medications priced separately. The program includes coaching alongside the prescription track. For patients who want behavioral support built into the same subscription, Found offers that without the premium pricing of fully staffed programs like Form Health or Calibrate.
Quick Comparison
| Provider | Sema Starting Price | Tirz Starting Price | All 50 States | Pharmacy Named |
| HealthRX | ~$99/mo | ~$149/mo | Yes | Yes (Manifest, SC) |
| FormBlends | ~$299/vial | ~$349/vial | No (47 states) | Yes (503A registered) |
| Mochi Health | ~$99/mo | ~$199/mo | Yes | Not published |
| Ro Body | Membership + meds separate | Membership + meds separate | Yes | N/A (branded) |
| Hims & Hers | ~$249-299/mo (branded) | ~$399/mo (branded) | Yes | N/A (branded) |
| PlushCare | ~$19.99/mo membership | Meds separate | Yes | N/A (branded) |
| Found | ~$99/mo platform | Meds separate | Yes | Not published |
FAQ
Are compounded semaglutide and branded Ozempic or Wegovy the same thing?
No. Compounded medications are not FDA-approved and cannot legally be claimed equivalent to branded drugs. They may contain the same active ingredient, but manufacturing standards, excipients, and regulatory oversight differ. Any provider making equivalency claims is out of compliance.
Why does pharmacy identification matter when choosing a provider?
The FDA issued warning letters to more than 30 compounding-related telehealth firms in early 2026, largely over quality and labeling issues. Knowing the specific pharmacy, its accreditation, and its testing practices gives you something to verify independently. A provider that won’t name the lab is a provider that can’t let you check.
Is the $99/mo starting price the actual monthly cost, or does it rise?
Dose typically increases over the first few months of a GLP-1 protocol, and pricing usually follows the dose tier. Confirm the full dosing schedule and corresponding prices before committing to any platform. Starting price and maintenance price are often different numbers.
Can I use insurance with these services?
It depends on the platform and the medication. Compounded GLP-1s are cash-pay by nature since insurance does not cover compounded drugs. Branded medications through providers like Hims & Hers, Ro, or PlushCare may be covered, but prior authorization requirements vary and approval is not guaranteed.
What happened to compounded GLP-1 availability after March 2026?
Following a settlement between Novo Nordisk and compounding industry parties in March 2026, several platforms shifted away from compounded semaglutide toward branded products. Others continued offering compounded versions under the 503A pharmacy framework. The regulatory picture is still evolving, so checking a provider’s current formulary before signing up is worth doing.
Sources
- FDA: 503A compounding pharmacy regulations and 2026 warning letter activity (FDA.gov)
- SURMOUNT-1 trial: tirzepatide efficacy data, published in *The New England Journal of Medicine*, 2022
- STEP 1 trial: semaglutide efficacy data, published in *The New England Journal of Medicine*, 2021
- LegitScript healthcare merchant certification database (LegitScript.com)
- Novo Nordisk compounding settlement reporting, March 2026 (Reuters, Stat News)
- Individual provider pricing pages, accessed 2026
